Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Index by author

December 01, 2021; Volume 379,Issue 3
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Abbruscato, Thomas J.

    1. You have access
      Glutamate Buffering Capacity and Blood-Brain Barrier Protection of Opioid Receptor Agonists Biphalin and Nociceptin
      Saeideh Nozohouri, Yong Zhang, Thamer H. Albekairi, Bhuvaneshwar Vaidya and Thomas J. Abbruscato
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 260-269; DOI: https://doi.org/10.1124/jpet.121.000831
  2. Albekairi, Thamer H.

    1. You have access
      Glutamate Buffering Capacity and Blood-Brain Barrier Protection of Opioid Receptor Agonists Biphalin and Nociceptin
      Saeideh Nozohouri, Yong Zhang, Thamer H. Albekairi, Bhuvaneshwar Vaidya and Thomas J. Abbruscato
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 260-269; DOI: https://doi.org/10.1124/jpet.121.000831
  3. Aoyama, Kazunobu

    1. Open Access
      Selective Acetyl-CoA Carboxylase 1 Inhibitor Improves Hepatic Steatosis and Hepatic Fibrosis in a Preclinical Nonalcoholic Steatohepatitis Model
      Yumiko Okano Tamura, Jun Sugama, Shinji Iwasaki, Masako Sasaki, Hironobu Yasuno, Kazunobu Aoyama, Masanori Watanabe, Derek M. Erion and Hiroaki Yashiro
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 280-289; DOI: https://doi.org/10.1124/jpet.121.000786

B

  1. Bindra, Ranjit S.

    1. You have access
      Brain Distribution of Berzosertib: An Ataxia Telangiectasia and Rad3-Related Protein Inhibitor for the Treatment of Glioblastoma
      Surabhi Talele, Wenjuan Zhang, Danielle M. Burgenske, Minjee Kim, Afroz S. Mohammad, Sonja Dragojevic, Shiv K. Gupta, Ranjit S. Bindra, Jann N. Sarkaria and William F. Elmquist
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 343-357; DOI: https://doi.org/10.1124/jpet.121.000845
  2. Biswas, Shameek

    1. Open Access
      Deconstructing the Pharmacological Contribution of Sphingosine-1 Phosphate Receptors to Mouse Models of Multiple Sclerosis Using the Species Selectivity of Ozanimod, a Dual Modulator of Human Sphingosine 1-Phosphate Receptor Subtypes 1 and 5
      Julie V. Selkirk, Kevin C. Dines, Yingzhuo Grace Yan, Nathan Ching, Deepak Dalvie, Shameek Biswas, Andrea Bortolato, Jeffrey M. Schkeryantz, Carlos Lopez, Iliana Ruiz and Richard Hargreaves
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 386-399; DOI: https://doi.org/10.1124/jpet.121.000741
  3. Bortolato, Andrea

    1. Open Access
      Deconstructing the Pharmacological Contribution of Sphingosine-1 Phosphate Receptors to Mouse Models of Multiple Sclerosis Using the Species Selectivity of Ozanimod, a Dual Modulator of Human Sphingosine 1-Phosphate Receptor Subtypes 1 and 5
      Julie V. Selkirk, Kevin C. Dines, Yingzhuo Grace Yan, Nathan Ching, Deepak Dalvie, Shameek Biswas, Andrea Bortolato, Jeffrey M. Schkeryantz, Carlos Lopez, Iliana Ruiz and Richard Hargreaves
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 386-399; DOI: https://doi.org/10.1124/jpet.121.000741
  4. Bresinsky, Merlin

    1. You have access
      Cardiac Effects of Novel Histamine H2 Receptor Agonists
      Ulrich Gergs, Maren L. Büxel, Merlin Bresinsky, Uwe Kirchhefer, Charlotte Fehse, Carina Höring, Britt Hofmann, Margaréta Marušáková, Aneta Čináková, Rebecca Schwarz, Steffen Pockes and Joachim Neumann
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 223-234; DOI: https://doi.org/10.1124/jpet.121.000822
  5. Bruce, Mark

    1. You have access
      Novel Platform for Predicting Drug Effects in Patients with Acromegaly: Translational Exposure-Response Evaluation of Growth Hormone–Inhibitory Effect of Octreotide after Growth Hormone–Releasing Hormone Stimulation
      Hiroyuki Iida, Tatsuya Komagata, Hirotaka Tanaka, Ryusuke Nagasawa, Takuya Nishio, Tomoyuki Shono, Junsaku Kitagawa, Ken-ichi Ogawara, Koji Shinozaki, Akiteru Seki, Mark Bruce and Tomoya Ohno
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 400-408; DOI: https://doi.org/10.1124/jpet.121.000769
  6. Bu, Mengfei

    1. You have access
      Methamphetamine Dysregulation of the Central Nervous System and Peripheral Immunity
      Douglas R. Miller, Mengfei Bu, Adithya Gopinath, Luis R. Martinez and Habibeh Khoshbouei
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 372-385; DOI: https://doi.org/10.1124/jpet.121.000767
  7. Burgenske, Danielle M.

    1. You have access
      Brain Distribution of Berzosertib: An Ataxia Telangiectasia and Rad3-Related Protein Inhibitor for the Treatment of Glioblastoma
      Surabhi Talele, Wenjuan Zhang, Danielle M. Burgenske, Minjee Kim, Afroz S. Mohammad, Sonja Dragojevic, Shiv K. Gupta, Ranjit S. Bindra, Jann N. Sarkaria and William F. Elmquist
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 343-357; DOI: https://doi.org/10.1124/jpet.121.000845
  8. Büxel, Maren L.

    1. You have access
      Cardiac Effects of Novel Histamine H2 Receptor Agonists
      Ulrich Gergs, Maren L. Büxel, Merlin Bresinsky, Uwe Kirchhefer, Charlotte Fehse, Carina Höring, Britt Hofmann, Margaréta Marušáková, Aneta Čináková, Rebecca Schwarz, Steffen Pockes and Joachim Neumann
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 223-234; DOI: https://doi.org/10.1124/jpet.121.000822

C

  1. Castaneda, Thaddaeus R.

    1. Physiologic, Metabolic, and Toxicologic Profile of 1,3-Butanediol
      You have access
      Physiologic, Metabolic, and Toxicologic Profile of 1,3-Butanediol
      Cameron G. McCarthy, Emily W. Waigi, Gagandeep Singh, Thaddaeus R. Castaneda, Blair Mell, Saroj Chakraborty, Camilla F. Wenceslau and Bina Joe
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 245-252; DOI: https://doi.org/10.1124/jpet.121.000796
  2. Castillo, Genessis

    1. Differential Susceptibilities of Catecholamines to Metabolism by Monoamine Oxidases
      You have access
      Differential Susceptibilities of Catecholamines to Metabolism by Monoamine Oxidases
      David S. Goldstein, Genessis Castillo, Patti Sullivan and Yehonatan Sharabi
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 253-259; DOI: https://doi.org/10.1124/jpet.121.000826
  3. Chakraborty, Saroj

    1. Physiologic, Metabolic, and Toxicologic Profile of 1,3-Butanediol
      You have access
      Physiologic, Metabolic, and Toxicologic Profile of 1,3-Butanediol
      Cameron G. McCarthy, Emily W. Waigi, Gagandeep Singh, Thaddaeus R. Castaneda, Blair Mell, Saroj Chakraborty, Camilla F. Wenceslau and Bina Joe
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 245-252; DOI: https://doi.org/10.1124/jpet.121.000796
  4. Ching, Nathan

    1. Open Access
      Deconstructing the Pharmacological Contribution of Sphingosine-1 Phosphate Receptors to Mouse Models of Multiple Sclerosis Using the Species Selectivity of Ozanimod, a Dual Modulator of Human Sphingosine 1-Phosphate Receptor Subtypes 1 and 5
      Julie V. Selkirk, Kevin C. Dines, Yingzhuo Grace Yan, Nathan Ching, Deepak Dalvie, Shameek Biswas, Andrea Bortolato, Jeffrey M. Schkeryantz, Carlos Lopez, Iliana Ruiz and Richard Hargreaves
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 386-399; DOI: https://doi.org/10.1124/jpet.121.000741
  5. Čináková, Aneta

    1. You have access
      Cardiac Effects of Novel Histamine H2 Receptor Agonists
      Ulrich Gergs, Maren L. Büxel, Merlin Bresinsky, Uwe Kirchhefer, Charlotte Fehse, Carina Höring, Britt Hofmann, Margaréta Marušáková, Aneta Čináková, Rebecca Schwarz, Steffen Pockes and Joachim Neumann
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 223-234; DOI: https://doi.org/10.1124/jpet.121.000822
  6. Cowen, Benjamin R.

    1. Modulation of Oxidative Phosphorylation with IM156 Attenuates Mitochondrial Metabolic Reprogramming and Inhibits Pulmonary Fibrosis
      Open Access
      Modulation of Oxidative Phosphorylation with IM156 Attenuates Mitochondrial Metabolic Reprogramming and Inhibits Pulmonary Fibrosis
      Robert N. Willette, Parth Mangrolia, Stephen M. Pondell, Christopher Young Woo Lee, Sanghee Yoo, Marc S. Rudoltz, Benjamin R. Cowen and Dean J. Welsch
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 290-300; DOI: https://doi.org/10.1124/jpet.121.000811

D

  1. D’Ambrosio, Raimondo

    1. You have access
      Therapeutic Effects of Time-Limited Treatment with Brivaracetam on Posttraumatic Epilepsy after Fluid Percussion Injury in the Rat
      Clifford L. Eastman, Jason S. Fender, Pavel Klein and Raimondo D’Ambrosio
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 310-323; DOI: https://doi.org/10.1124/jpet.121.000585
  2. Dalvie, Deepak

    1. Open Access
      Deconstructing the Pharmacological Contribution of Sphingosine-1 Phosphate Receptors to Mouse Models of Multiple Sclerosis Using the Species Selectivity of Ozanimod, a Dual Modulator of Human Sphingosine 1-Phosphate Receptor Subtypes 1 and 5
      Julie V. Selkirk, Kevin C. Dines, Yingzhuo Grace Yan, Nathan Ching, Deepak Dalvie, Shameek Biswas, Andrea Bortolato, Jeffrey M. Schkeryantz, Carlos Lopez, Iliana Ruiz and Richard Hargreaves
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 386-399; DOI: https://doi.org/10.1124/jpet.121.000741
  3. De Luca, Vivien

    1. You have access
      Selective Inhibition of N-Methyl-d-aspartate Receptors with GluN2B Subunit Protects β Cells against Stress-Induced Apoptotic Cell Death
      Anne Gresch, Héctor Noguera Hurtado, Laura Wörmeyer, Vivien De Luca, Rebekka Wiggers, Guiscard Seebohm, Bernhard Wünsch and Martina Düfer
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 235-244; DOI: https://doi.org/10.1124/jpet.121.000807
  4. Dines, Kevin C.

    1. Open Access
      Deconstructing the Pharmacological Contribution of Sphingosine-1 Phosphate Receptors to Mouse Models of Multiple Sclerosis Using the Species Selectivity of Ozanimod, a Dual Modulator of Human Sphingosine 1-Phosphate Receptor Subtypes 1 and 5
      Julie V. Selkirk, Kevin C. Dines, Yingzhuo Grace Yan, Nathan Ching, Deepak Dalvie, Shameek Biswas, Andrea Bortolato, Jeffrey M. Schkeryantz, Carlos Lopez, Iliana Ruiz and Richard Hargreaves
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 386-399; DOI: https://doi.org/10.1124/jpet.121.000741
  5. Dong, Xiaohu

    1. You have access
      A Novel Etomidate Analog EL-0052 Retains Potent Hypnotic Effect and Stable Hemodynamics without Suppressing Adrenocortical Function
      Xiangqing Xu, Yaqin Wei, Yingying Dong, Yinli Qiu, Zhanbiao Mei, Kai Wang, Jingya Xiu, Tao Wang, Lingguo Zeng, Xiaohu Dong, Yi Shen, Wengao Jiang and Qingeng Li
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 324-330; DOI: https://doi.org/10.1124/jpet.121.000691
  6. Dong, Yingying

    1. You have access
      A Novel Etomidate Analog EL-0052 Retains Potent Hypnotic Effect and Stable Hemodynamics without Suppressing Adrenocortical Function
      Xiangqing Xu, Yaqin Wei, Yingying Dong, Yinli Qiu, Zhanbiao Mei, Kai Wang, Jingya Xiu, Tao Wang, Lingguo Zeng, Xiaohu Dong, Yi Shen, Wengao Jiang and Qingeng Li
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 324-330; DOI: https://doi.org/10.1124/jpet.121.000691
  7. Dragojevic, Sonja

    1. You have access
      Brain Distribution of Berzosertib: An Ataxia Telangiectasia and Rad3-Related Protein Inhibitor for the Treatment of Glioblastoma
      Surabhi Talele, Wenjuan Zhang, Danielle M. Burgenske, Minjee Kim, Afroz S. Mohammad, Sonja Dragojevic, Shiv K. Gupta, Ranjit S. Bindra, Jann N. Sarkaria and William F. Elmquist
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 343-357; DOI: https://doi.org/10.1124/jpet.121.000845
  8. Düfer, Martina

    1. You have access
      Selective Inhibition of N-Methyl-d-aspartate Receptors with GluN2B Subunit Protects β Cells against Stress-Induced Apoptotic Cell Death
      Anne Gresch, Héctor Noguera Hurtado, Laura Wörmeyer, Vivien De Luca, Rebekka Wiggers, Guiscard Seebohm, Bernhard Wünsch and Martina Düfer
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 235-244; DOI: https://doi.org/10.1124/jpet.121.000807

E

  1. Eastman, Clifford L.

    1. You have access
      Therapeutic Effects of Time-Limited Treatment with Brivaracetam on Posttraumatic Epilepsy after Fluid Percussion Injury in the Rat
      Clifford L. Eastman, Jason S. Fender, Pavel Klein and Raimondo D’Ambrosio
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 310-323; DOI: https://doi.org/10.1124/jpet.121.000585
  2. Elmquist, William F.

    1. You have access
      Brain Distribution of Berzosertib: An Ataxia Telangiectasia and Rad3-Related Protein Inhibitor for the Treatment of Glioblastoma
      Surabhi Talele, Wenjuan Zhang, Danielle M. Burgenske, Minjee Kim, Afroz S. Mohammad, Sonja Dragojevic, Shiv K. Gupta, Ranjit S. Bindra, Jann N. Sarkaria and William F. Elmquist
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 343-357; DOI: https://doi.org/10.1124/jpet.121.000845
  3. Erion, Derek M.

    1. Open Access
      Selective Acetyl-CoA Carboxylase 1 Inhibitor Improves Hepatic Steatosis and Hepatic Fibrosis in a Preclinical Nonalcoholic Steatohepatitis Model
      Yumiko Okano Tamura, Jun Sugama, Shinji Iwasaki, Masako Sasaki, Hironobu Yasuno, Kazunobu Aoyama, Masanori Watanabe, Derek M. Erion and Hiroaki Yashiro
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 280-289; DOI: https://doi.org/10.1124/jpet.121.000786

F

  1. Fehse, Charlotte

    1. You have access
      Cardiac Effects of Novel Histamine H2 Receptor Agonists
      Ulrich Gergs, Maren L. Büxel, Merlin Bresinsky, Uwe Kirchhefer, Charlotte Fehse, Carina Höring, Britt Hofmann, Margaréta Marušáková, Aneta Čináková, Rebecca Schwarz, Steffen Pockes and Joachim Neumann
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 223-234; DOI: https://doi.org/10.1124/jpet.121.000822
  2. Fender, Jason S.

    1. You have access
      Therapeutic Effects of Time-Limited Treatment with Brivaracetam on Posttraumatic Epilepsy after Fluid Percussion Injury in the Rat
      Clifford L. Eastman, Jason S. Fender, Pavel Klein and Raimondo D’Ambrosio
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 310-323; DOI: https://doi.org/10.1124/jpet.121.000585

G

  1. Gergs, Ulrich

    1. You have access
      Cardiac Effects of Novel Histamine H2 Receptor Agonists
      Ulrich Gergs, Maren L. Büxel, Merlin Bresinsky, Uwe Kirchhefer, Charlotte Fehse, Carina Höring, Britt Hofmann, Margaréta Marušáková, Aneta Čináková, Rebecca Schwarz, Steffen Pockes and Joachim Neumann
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 223-234; DOI: https://doi.org/10.1124/jpet.121.000822
  2. Goldstein, David S.

    1. Differential Susceptibilities of Catecholamines to Metabolism by Monoamine Oxidases
      You have access
      Differential Susceptibilities of Catecholamines to Metabolism by Monoamine Oxidases
      David S. Goldstein, Genessis Castillo, Patti Sullivan and Yehonatan Sharabi
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 253-259; DOI: https://doi.org/10.1124/jpet.121.000826
  3. Gopinath, Adithya

    1. You have access
      Methamphetamine Dysregulation of the Central Nervous System and Peripheral Immunity
      Douglas R. Miller, Mengfei Bu, Adithya Gopinath, Luis R. Martinez and Habibeh Khoshbouei
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 372-385; DOI: https://doi.org/10.1124/jpet.121.000767
  4. Greenwood-Van Meerveld, Beverley

    1. Open Access
      A Monoclonal Anti–Calcitonin Gene-Related Peptide Antibody Decreases Stress-Induced Colonic Hypersensitivity
      Ehsan Noor-Mohammadi, Casey Owen Ligon, Kimberly Mackenzie, Jennifer Stratton, Sara Shnider and Beverley Greenwood-Van Meerveld
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 270-279; DOI: https://doi.org/10.1124/jpet.121.000731
  5. Gresch, Anne

    1. You have access
      Selective Inhibition of N-Methyl-d-aspartate Receptors with GluN2B Subunit Protects β Cells against Stress-Induced Apoptotic Cell Death
      Anne Gresch, Héctor Noguera Hurtado, Laura Wörmeyer, Vivien De Luca, Rebekka Wiggers, Guiscard Seebohm, Bernhard Wünsch and Martina Düfer
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 235-244; DOI: https://doi.org/10.1124/jpet.121.000807
  6. Gupta, Shiv K.

    1. You have access
      Brain Distribution of Berzosertib: An Ataxia Telangiectasia and Rad3-Related Protein Inhibitor for the Treatment of Glioblastoma
      Surabhi Talele, Wenjuan Zhang, Danielle M. Burgenske, Minjee Kim, Afroz S. Mohammad, Sonja Dragojevic, Shiv K. Gupta, Ranjit S. Bindra, Jann N. Sarkaria and William F. Elmquist
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 343-357; DOI: https://doi.org/10.1124/jpet.121.000845
  7. Gustafson, Daniel L.

    1. You have access
      Pharmacokinetic and Pharmacodynamic Assessment of Hydroxychloroquine in Breast Cancer
      Kristen M. Van Eaton and Daniel L. Gustafson
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 331-342; DOI: https://doi.org/10.1124/jpet.121.000730

H

  1. Hargreaves, Richard

    1. Open Access
      Deconstructing the Pharmacological Contribution of Sphingosine-1 Phosphate Receptors to Mouse Models of Multiple Sclerosis Using the Species Selectivity of Ozanimod, a Dual Modulator of Human Sphingosine 1-Phosphate Receptor Subtypes 1 and 5
      Julie V. Selkirk, Kevin C. Dines, Yingzhuo Grace Yan, Nathan Ching, Deepak Dalvie, Shameek Biswas, Andrea Bortolato, Jeffrey M. Schkeryantz, Carlos Lopez, Iliana Ruiz and Richard Hargreaves
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 386-399; DOI: https://doi.org/10.1124/jpet.121.000741
  2. Hofmann, Britt

    1. You have access
      Cardiac Effects of Novel Histamine H2 Receptor Agonists
      Ulrich Gergs, Maren L. Büxel, Merlin Bresinsky, Uwe Kirchhefer, Charlotte Fehse, Carina Höring, Britt Hofmann, Margaréta Marušáková, Aneta Čináková, Rebecca Schwarz, Steffen Pockes and Joachim Neumann
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 223-234; DOI: https://doi.org/10.1124/jpet.121.000822
  3. Höring, Carina

    1. You have access
      Cardiac Effects of Novel Histamine H2 Receptor Agonists
      Ulrich Gergs, Maren L. Büxel, Merlin Bresinsky, Uwe Kirchhefer, Charlotte Fehse, Carina Höring, Britt Hofmann, Margaréta Marušáková, Aneta Čináková, Rebecca Schwarz, Steffen Pockes and Joachim Neumann
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 223-234; DOI: https://doi.org/10.1124/jpet.121.000822
  4. Huang, Xiangao

    1. You have access
      Caspase-8 Regulates the Antimyeloma Activity of Bortezomib and Lenalidomide
      Liang Zhou, Xiangao Huang, Ruben Niesvizky, Zhongjian Pu and Guoqiang Xu
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 303-309; DOI: https://doi.org/10.1124/jpet.121.000818
  5. Huddar, Srigouri

    1. Allosteric Inhibition of the Tumor-Promoting Interaction Between Exon 2–Depleted Splice Variant of Aminoacyl–Transfer RNA Synthetase-Interacting Multifunctional Protein 2 and Heat Shock Protein 70
      Open Access
      Allosteric Inhibition of the Tumor-Promoting Interaction Between Exon 2–Depleted Splice Variant of Aminoacyl–Transfer RNA Synthetase-Interacting Multifunctional Protein 2 and Heat Shock Protein 70
      Dae Gyu Kim, Srigouri Huddar, Semi Lim, Jiwon Kong, Yuno Lee, Chul Min Park, Seungbeom Lee, Young-Ger Suh, Minkyoung Kim, Kyeong Lee, Sunkyung Lee and Sunghoon Kim
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 358-371; DOI: https://doi.org/10.1124/jpet.121.000766
  6. Hurtado, Héctor Noguera

    1. You have access
      Selective Inhibition of N-Methyl-d-aspartate Receptors with GluN2B Subunit Protects β Cells against Stress-Induced Apoptotic Cell Death
      Anne Gresch, Héctor Noguera Hurtado, Laura Wörmeyer, Vivien De Luca, Rebekka Wiggers, Guiscard Seebohm, Bernhard Wünsch and Martina Düfer
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 235-244; DOI: https://doi.org/10.1124/jpet.121.000807

I

  1. Iida, Hiroyuki

    1. You have access
      Novel Platform for Predicting Drug Effects in Patients with Acromegaly: Translational Exposure-Response Evaluation of Growth Hormone–Inhibitory Effect of Octreotide after Growth Hormone–Releasing Hormone Stimulation
      Hiroyuki Iida, Tatsuya Komagata, Hirotaka Tanaka, Ryusuke Nagasawa, Takuya Nishio, Tomoyuki Shono, Junsaku Kitagawa, Ken-ichi Ogawara, Koji Shinozaki, Akiteru Seki, Mark Bruce and Tomoya Ohno
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 400-408; DOI: https://doi.org/10.1124/jpet.121.000769
  2. Iwasaki, Shinji

    1. Open Access
      Selective Acetyl-CoA Carboxylase 1 Inhibitor Improves Hepatic Steatosis and Hepatic Fibrosis in a Preclinical Nonalcoholic Steatohepatitis Model
      Yumiko Okano Tamura, Jun Sugama, Shinji Iwasaki, Masako Sasaki, Hironobu Yasuno, Kazunobu Aoyama, Masanori Watanabe, Derek M. Erion and Hiroaki Yashiro
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 280-289; DOI: https://doi.org/10.1124/jpet.121.000786

J

  1. Jiang, Wengao

    1. You have access
      A Novel Etomidate Analog EL-0052 Retains Potent Hypnotic Effect and Stable Hemodynamics without Suppressing Adrenocortical Function
      Xiangqing Xu, Yaqin Wei, Yingying Dong, Yinli Qiu, Zhanbiao Mei, Kai Wang, Jingya Xiu, Tao Wang, Lingguo Zeng, Xiaohu Dong, Yi Shen, Wengao Jiang and Qingeng Li
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 324-330; DOI: https://doi.org/10.1124/jpet.121.000691
  2. Joe, Bina

    1. Physiologic, Metabolic, and Toxicologic Profile of 1,3-Butanediol
      You have access
      Physiologic, Metabolic, and Toxicologic Profile of 1,3-Butanediol
      Cameron G. McCarthy, Emily W. Waigi, Gagandeep Singh, Thaddaeus R. Castaneda, Blair Mell, Saroj Chakraborty, Camilla F. Wenceslau and Bina Joe
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 245-252; DOI: https://doi.org/10.1124/jpet.121.000796

K

  1. Khoshbouei, Habibeh

    1. You have access
      Methamphetamine Dysregulation of the Central Nervous System and Peripheral Immunity
      Douglas R. Miller, Mengfei Bu, Adithya Gopinath, Luis R. Martinez and Habibeh Khoshbouei
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 372-385; DOI: https://doi.org/10.1124/jpet.121.000767
  2. Kim, Dae Gyu

    1. Allosteric Inhibition of the Tumor-Promoting Interaction Between Exon 2–Depleted Splice Variant of Aminoacyl–Transfer RNA Synthetase-Interacting Multifunctional Protein 2 and Heat Shock Protein 70
      Open Access
      Allosteric Inhibition of the Tumor-Promoting Interaction Between Exon 2–Depleted Splice Variant of Aminoacyl–Transfer RNA Synthetase-Interacting Multifunctional Protein 2 and Heat Shock Protein 70
      Dae Gyu Kim, Srigouri Huddar, Semi Lim, Jiwon Kong, Yuno Lee, Chul Min Park, Seungbeom Lee, Young-Ger Suh, Minkyoung Kim, Kyeong Lee, Sunkyung Lee and Sunghoon Kim
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 358-371; DOI: https://doi.org/10.1124/jpet.121.000766
  3. Kim, Minjee

    1. You have access
      Brain Distribution of Berzosertib: An Ataxia Telangiectasia and Rad3-Related Protein Inhibitor for the Treatment of Glioblastoma
      Surabhi Talele, Wenjuan Zhang, Danielle M. Burgenske, Minjee Kim, Afroz S. Mohammad, Sonja Dragojevic, Shiv K. Gupta, Ranjit S. Bindra, Jann N. Sarkaria and William F. Elmquist
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 343-357; DOI: https://doi.org/10.1124/jpet.121.000845
  4. Kim, Minkyoung

    1. Allosteric Inhibition of the Tumor-Promoting Interaction Between Exon 2–Depleted Splice Variant of Aminoacyl–Transfer RNA Synthetase-Interacting Multifunctional Protein 2 and Heat Shock Protein 70
      Open Access
      Allosteric Inhibition of the Tumor-Promoting Interaction Between Exon 2–Depleted Splice Variant of Aminoacyl–Transfer RNA Synthetase-Interacting Multifunctional Protein 2 and Heat Shock Protein 70
      Dae Gyu Kim, Srigouri Huddar, Semi Lim, Jiwon Kong, Yuno Lee, Chul Min Park, Seungbeom Lee, Young-Ger Suh, Minkyoung Kim, Kyeong Lee, Sunkyung Lee and Sunghoon Kim
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 358-371; DOI: https://doi.org/10.1124/jpet.121.000766
  5. Kim, Sunghoon

    1. Allosteric Inhibition of the Tumor-Promoting Interaction Between Exon 2–Depleted Splice Variant of Aminoacyl–Transfer RNA Synthetase-Interacting Multifunctional Protein 2 and Heat Shock Protein 70
      Open Access
      Allosteric Inhibition of the Tumor-Promoting Interaction Between Exon 2–Depleted Splice Variant of Aminoacyl–Transfer RNA Synthetase-Interacting Multifunctional Protein 2 and Heat Shock Protein 70
      Dae Gyu Kim, Srigouri Huddar, Semi Lim, Jiwon Kong, Yuno Lee, Chul Min Park, Seungbeom Lee, Young-Ger Suh, Minkyoung Kim, Kyeong Lee, Sunkyung Lee and Sunghoon Kim
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 358-371; DOI: https://doi.org/10.1124/jpet.121.000766
  6. Kirchhefer, Uwe

    1. You have access
      Cardiac Effects of Novel Histamine H2 Receptor Agonists
      Ulrich Gergs, Maren L. Büxel, Merlin Bresinsky, Uwe Kirchhefer, Charlotte Fehse, Carina Höring, Britt Hofmann, Margaréta Marušáková, Aneta Čináková, Rebecca Schwarz, Steffen Pockes and Joachim Neumann
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 223-234; DOI: https://doi.org/10.1124/jpet.121.000822
  7. Kitagawa, Junsaku

    1. You have access
      Novel Platform for Predicting Drug Effects in Patients with Acromegaly: Translational Exposure-Response Evaluation of Growth Hormone–Inhibitory Effect of Octreotide after Growth Hormone–Releasing Hormone Stimulation
      Hiroyuki Iida, Tatsuya Komagata, Hirotaka Tanaka, Ryusuke Nagasawa, Takuya Nishio, Tomoyuki Shono, Junsaku Kitagawa, Ken-ichi Ogawara, Koji Shinozaki, Akiteru Seki, Mark Bruce and Tomoya Ohno
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 400-408; DOI: https://doi.org/10.1124/jpet.121.000769
  8. Klein, Pavel

    1. You have access
      Therapeutic Effects of Time-Limited Treatment with Brivaracetam on Posttraumatic Epilepsy after Fluid Percussion Injury in the Rat
      Clifford L. Eastman, Jason S. Fender, Pavel Klein and Raimondo D’Ambrosio
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 310-323; DOI: https://doi.org/10.1124/jpet.121.000585
  9. Komagata, Tatsuya

    1. You have access
      Novel Platform for Predicting Drug Effects in Patients with Acromegaly: Translational Exposure-Response Evaluation of Growth Hormone–Inhibitory Effect of Octreotide after Growth Hormone–Releasing Hormone Stimulation
      Hiroyuki Iida, Tatsuya Komagata, Hirotaka Tanaka, Ryusuke Nagasawa, Takuya Nishio, Tomoyuki Shono, Junsaku Kitagawa, Ken-ichi Ogawara, Koji Shinozaki, Akiteru Seki, Mark Bruce and Tomoya Ohno
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 400-408; DOI: https://doi.org/10.1124/jpet.121.000769
  10. Kong, Jiwon

    1. Allosteric Inhibition of the Tumor-Promoting Interaction Between Exon 2–Depleted Splice Variant of Aminoacyl–Transfer RNA Synthetase-Interacting Multifunctional Protein 2 and Heat Shock Protein 70
      Open Access
      Allosteric Inhibition of the Tumor-Promoting Interaction Between Exon 2–Depleted Splice Variant of Aminoacyl–Transfer RNA Synthetase-Interacting Multifunctional Protein 2 and Heat Shock Protein 70
      Dae Gyu Kim, Srigouri Huddar, Semi Lim, Jiwon Kong, Yuno Lee, Chul Min Park, Seungbeom Lee, Young-Ger Suh, Minkyoung Kim, Kyeong Lee, Sunkyung Lee and Sunghoon Kim
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 358-371; DOI: https://doi.org/10.1124/jpet.121.000766

L

  1. Lee, Christopher Young Woo

    1. Modulation of Oxidative Phosphorylation with IM156 Attenuates Mitochondrial Metabolic Reprogramming and Inhibits Pulmonary Fibrosis
      Open Access
      Modulation of Oxidative Phosphorylation with IM156 Attenuates Mitochondrial Metabolic Reprogramming and Inhibits Pulmonary Fibrosis
      Robert N. Willette, Parth Mangrolia, Stephen M. Pondell, Christopher Young Woo Lee, Sanghee Yoo, Marc S. Rudoltz, Benjamin R. Cowen and Dean J. Welsch
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 290-300; DOI: https://doi.org/10.1124/jpet.121.000811
  2. Lee, Kyeong

    1. Allosteric Inhibition of the Tumor-Promoting Interaction Between Exon 2–Depleted Splice Variant of Aminoacyl–Transfer RNA Synthetase-Interacting Multifunctional Protein 2 and Heat Shock Protein 70
      Open Access
      Allosteric Inhibition of the Tumor-Promoting Interaction Between Exon 2–Depleted Splice Variant of Aminoacyl–Transfer RNA Synthetase-Interacting Multifunctional Protein 2 and Heat Shock Protein 70
      Dae Gyu Kim, Srigouri Huddar, Semi Lim, Jiwon Kong, Yuno Lee, Chul Min Park, Seungbeom Lee, Young-Ger Suh, Minkyoung Kim, Kyeong Lee, Sunkyung Lee and Sunghoon Kim
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 358-371; DOI: https://doi.org/10.1124/jpet.121.000766
  3. Lee, Seungbeom

    1. Allosteric Inhibition of the Tumor-Promoting Interaction Between Exon 2–Depleted Splice Variant of Aminoacyl–Transfer RNA Synthetase-Interacting Multifunctional Protein 2 and Heat Shock Protein 70
      Open Access
      Allosteric Inhibition of the Tumor-Promoting Interaction Between Exon 2–Depleted Splice Variant of Aminoacyl–Transfer RNA Synthetase-Interacting Multifunctional Protein 2 and Heat Shock Protein 70
      Dae Gyu Kim, Srigouri Huddar, Semi Lim, Jiwon Kong, Yuno Lee, Chul Min Park, Seungbeom Lee, Young-Ger Suh, Minkyoung Kim, Kyeong Lee, Sunkyung Lee and Sunghoon Kim
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 358-371; DOI: https://doi.org/10.1124/jpet.121.000766
  4. Lee, Sunkyung

    1. Allosteric Inhibition of the Tumor-Promoting Interaction Between Exon 2–Depleted Splice Variant of Aminoacyl–Transfer RNA Synthetase-Interacting Multifunctional Protein 2 and Heat Shock Protein 70
      Open Access
      Allosteric Inhibition of the Tumor-Promoting Interaction Between Exon 2–Depleted Splice Variant of Aminoacyl–Transfer RNA Synthetase-Interacting Multifunctional Protein 2 and Heat Shock Protein 70
      Dae Gyu Kim, Srigouri Huddar, Semi Lim, Jiwon Kong, Yuno Lee, Chul Min Park, Seungbeom Lee, Young-Ger Suh, Minkyoung Kim, Kyeong Lee, Sunkyung Lee and Sunghoon Kim
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 358-371; DOI: https://doi.org/10.1124/jpet.121.000766
  5. Lee, Yuno

    1. Allosteric Inhibition of the Tumor-Promoting Interaction Between Exon 2–Depleted Splice Variant of Aminoacyl–Transfer RNA Synthetase-Interacting Multifunctional Protein 2 and Heat Shock Protein 70
      Open Access
      Allosteric Inhibition of the Tumor-Promoting Interaction Between Exon 2–Depleted Splice Variant of Aminoacyl–Transfer RNA Synthetase-Interacting Multifunctional Protein 2 and Heat Shock Protein 70
      Dae Gyu Kim, Srigouri Huddar, Semi Lim, Jiwon Kong, Yuno Lee, Chul Min Park, Seungbeom Lee, Young-Ger Suh, Minkyoung Kim, Kyeong Lee, Sunkyung Lee and Sunghoon Kim
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 358-371; DOI: https://doi.org/10.1124/jpet.121.000766
  6. Li, Qingeng

    1. You have access
      A Novel Etomidate Analog EL-0052 Retains Potent Hypnotic Effect and Stable Hemodynamics without Suppressing Adrenocortical Function
      Xiangqing Xu, Yaqin Wei, Yingying Dong, Yinli Qiu, Zhanbiao Mei, Kai Wang, Jingya Xiu, Tao Wang, Lingguo Zeng, Xiaohu Dong, Yi Shen, Wengao Jiang and Qingeng Li
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 324-330; DOI: https://doi.org/10.1124/jpet.121.000691
  7. Ligon, Casey Owen

    1. Open Access
      A Monoclonal Anti–Calcitonin Gene-Related Peptide Antibody Decreases Stress-Induced Colonic Hypersensitivity
      Ehsan Noor-Mohammadi, Casey Owen Ligon, Kimberly Mackenzie, Jennifer Stratton, Sara Shnider and Beverley Greenwood-Van Meerveld
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 270-279; DOI: https://doi.org/10.1124/jpet.121.000731
  8. Lim, Semi

    1. Allosteric Inhibition of the Tumor-Promoting Interaction Between Exon 2–Depleted Splice Variant of Aminoacyl–Transfer RNA Synthetase-Interacting Multifunctional Protein 2 and Heat Shock Protein 70
      Open Access
      Allosteric Inhibition of the Tumor-Promoting Interaction Between Exon 2–Depleted Splice Variant of Aminoacyl–Transfer RNA Synthetase-Interacting Multifunctional Protein 2 and Heat Shock Protein 70
      Dae Gyu Kim, Srigouri Huddar, Semi Lim, Jiwon Kong, Yuno Lee, Chul Min Park, Seungbeom Lee, Young-Ger Suh, Minkyoung Kim, Kyeong Lee, Sunkyung Lee and Sunghoon Kim
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 358-371; DOI: https://doi.org/10.1124/jpet.121.000766
  9. Lopez, Carlos

    1. Open Access
      Deconstructing the Pharmacological Contribution of Sphingosine-1 Phosphate Receptors to Mouse Models of Multiple Sclerosis Using the Species Selectivity of Ozanimod, a Dual Modulator of Human Sphingosine 1-Phosphate Receptor Subtypes 1 and 5
      Julie V. Selkirk, Kevin C. Dines, Yingzhuo Grace Yan, Nathan Ching, Deepak Dalvie, Shameek Biswas, Andrea Bortolato, Jeffrey M. Schkeryantz, Carlos Lopez, Iliana Ruiz and Richard Hargreaves
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 386-399; DOI: https://doi.org/10.1124/jpet.121.000741

M

  1. Mackenzie, Kimberly

    1. Open Access
      A Monoclonal Anti–Calcitonin Gene-Related Peptide Antibody Decreases Stress-Induced Colonic Hypersensitivity
      Ehsan Noor-Mohammadi, Casey Owen Ligon, Kimberly Mackenzie, Jennifer Stratton, Sara Shnider and Beverley Greenwood-Van Meerveld
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 270-279; DOI: https://doi.org/10.1124/jpet.121.000731
  2. Mangrolia, Parth

    1. Modulation of Oxidative Phosphorylation with IM156 Attenuates Mitochondrial Metabolic Reprogramming and Inhibits Pulmonary Fibrosis
      Open Access
      Modulation of Oxidative Phosphorylation with IM156 Attenuates Mitochondrial Metabolic Reprogramming and Inhibits Pulmonary Fibrosis
      Robert N. Willette, Parth Mangrolia, Stephen M. Pondell, Christopher Young Woo Lee, Sanghee Yoo, Marc S. Rudoltz, Benjamin R. Cowen and Dean J. Welsch
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 290-300; DOI: https://doi.org/10.1124/jpet.121.000811
  3. Martinez, Luis R.

    1. You have access
      Methamphetamine Dysregulation of the Central Nervous System and Peripheral Immunity
      Douglas R. Miller, Mengfei Bu, Adithya Gopinath, Luis R. Martinez and Habibeh Khoshbouei
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 372-385; DOI: https://doi.org/10.1124/jpet.121.000767
  4. Marušáková, Margaréta

    1. You have access
      Cardiac Effects of Novel Histamine H2 Receptor Agonists
      Ulrich Gergs, Maren L. Büxel, Merlin Bresinsky, Uwe Kirchhefer, Charlotte Fehse, Carina Höring, Britt Hofmann, Margaréta Marušáková, Aneta Čináková, Rebecca Schwarz, Steffen Pockes and Joachim Neumann
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 223-234; DOI: https://doi.org/10.1124/jpet.121.000822
  5. McCarthy , Cameron G.

    1. Physiologic, Metabolic, and Toxicologic Profile of 1,3-Butanediol
      You have access
      Physiologic, Metabolic, and Toxicologic Profile of 1,3-Butanediol
      Cameron G. McCarthy, Emily W. Waigi, Gagandeep Singh, Thaddaeus R. Castaneda, Blair Mell, Saroj Chakraborty, Camilla F. Wenceslau and Bina Joe
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 245-252; DOI: https://doi.org/10.1124/jpet.121.000796
  6. Mei, Zhanbiao

    1. You have access
      A Novel Etomidate Analog EL-0052 Retains Potent Hypnotic Effect and Stable Hemodynamics without Suppressing Adrenocortical Function
      Xiangqing Xu, Yaqin Wei, Yingying Dong, Yinli Qiu, Zhanbiao Mei, Kai Wang, Jingya Xiu, Tao Wang, Lingguo Zeng, Xiaohu Dong, Yi Shen, Wengao Jiang and Qingeng Li
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 324-330; DOI: https://doi.org/10.1124/jpet.121.000691
  7. Mell, Blair

    1. Physiologic, Metabolic, and Toxicologic Profile of 1,3-Butanediol
      You have access
      Physiologic, Metabolic, and Toxicologic Profile of 1,3-Butanediol
      Cameron G. McCarthy, Emily W. Waigi, Gagandeep Singh, Thaddaeus R. Castaneda, Blair Mell, Saroj Chakraborty, Camilla F. Wenceslau and Bina Joe
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 245-252; DOI: https://doi.org/10.1124/jpet.121.000796
  8. Miller, Douglas R.

    1. You have access
      Methamphetamine Dysregulation of the Central Nervous System and Peripheral Immunity
      Douglas R. Miller, Mengfei Bu, Adithya Gopinath, Luis R. Martinez and Habibeh Khoshbouei
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 372-385; DOI: https://doi.org/10.1124/jpet.121.000767
  9. Mohammad, Afroz S.

    1. You have access
      Brain Distribution of Berzosertib: An Ataxia Telangiectasia and Rad3-Related Protein Inhibitor for the Treatment of Glioblastoma
      Surabhi Talele, Wenjuan Zhang, Danielle M. Burgenske, Minjee Kim, Afroz S. Mohammad, Sonja Dragojevic, Shiv K. Gupta, Ranjit S. Bindra, Jann N. Sarkaria and William F. Elmquist
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 343-357; DOI: https://doi.org/10.1124/jpet.121.000845

N

  1. Nagasawa, Ryusuke

    1. You have access
      Novel Platform for Predicting Drug Effects in Patients with Acromegaly: Translational Exposure-Response Evaluation of Growth Hormone–Inhibitory Effect of Octreotide after Growth Hormone–Releasing Hormone Stimulation
      Hiroyuki Iida, Tatsuya Komagata, Hirotaka Tanaka, Ryusuke Nagasawa, Takuya Nishio, Tomoyuki Shono, Junsaku Kitagawa, Ken-ichi Ogawara, Koji Shinozaki, Akiteru Seki, Mark Bruce and Tomoya Ohno
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 400-408; DOI: https://doi.org/10.1124/jpet.121.000769
  2. Neumann, Joachim

    1. You have access
      Cardiac Effects of Novel Histamine H2 Receptor Agonists
      Ulrich Gergs, Maren L. Büxel, Merlin Bresinsky, Uwe Kirchhefer, Charlotte Fehse, Carina Höring, Britt Hofmann, Margaréta Marušáková, Aneta Čináková, Rebecca Schwarz, Steffen Pockes and Joachim Neumann
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 223-234; DOI: https://doi.org/10.1124/jpet.121.000822
  3. Niesvizky, Ruben

    1. You have access
      Caspase-8 Regulates the Antimyeloma Activity of Bortezomib and Lenalidomide
      Liang Zhou, Xiangao Huang, Ruben Niesvizky, Zhongjian Pu and Guoqiang Xu
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 303-309; DOI: https://doi.org/10.1124/jpet.121.000818
  4. Nishio, Takuya

    1. You have access
      Novel Platform for Predicting Drug Effects in Patients with Acromegaly: Translational Exposure-Response Evaluation of Growth Hormone–Inhibitory Effect of Octreotide after Growth Hormone–Releasing Hormone Stimulation
      Hiroyuki Iida, Tatsuya Komagata, Hirotaka Tanaka, Ryusuke Nagasawa, Takuya Nishio, Tomoyuki Shono, Junsaku Kitagawa, Ken-ichi Ogawara, Koji Shinozaki, Akiteru Seki, Mark Bruce and Tomoya Ohno
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 400-408; DOI: https://doi.org/10.1124/jpet.121.000769
  5. Noor-Mohammadi, Ehsan

    1. Open Access
      A Monoclonal Anti–Calcitonin Gene-Related Peptide Antibody Decreases Stress-Induced Colonic Hypersensitivity
      Ehsan Noor-Mohammadi, Casey Owen Ligon, Kimberly Mackenzie, Jennifer Stratton, Sara Shnider and Beverley Greenwood-Van Meerveld
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 270-279; DOI: https://doi.org/10.1124/jpet.121.000731
  6. Nozohouri, Saeideh

    1. You have access
      Glutamate Buffering Capacity and Blood-Brain Barrier Protection of Opioid Receptor Agonists Biphalin and Nociceptin
      Saeideh Nozohouri, Yong Zhang, Thamer H. Albekairi, Bhuvaneshwar Vaidya and Thomas J. Abbruscato
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 260-269; DOI: https://doi.org/10.1124/jpet.121.000831

O

  1. Ogawara, Ken-ichi

    1. You have access
      Novel Platform for Predicting Drug Effects in Patients with Acromegaly: Translational Exposure-Response Evaluation of Growth Hormone–Inhibitory Effect of Octreotide after Growth Hormone–Releasing Hormone Stimulation
      Hiroyuki Iida, Tatsuya Komagata, Hirotaka Tanaka, Ryusuke Nagasawa, Takuya Nishio, Tomoyuki Shono, Junsaku Kitagawa, Ken-ichi Ogawara, Koji Shinozaki, Akiteru Seki, Mark Bruce and Tomoya Ohno
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 400-408; DOI: https://doi.org/10.1124/jpet.121.000769
  2. Ohno, Tomoya

    1. You have access
      Novel Platform for Predicting Drug Effects in Patients with Acromegaly: Translational Exposure-Response Evaluation of Growth Hormone–Inhibitory Effect of Octreotide after Growth Hormone–Releasing Hormone Stimulation
      Hiroyuki Iida, Tatsuya Komagata, Hirotaka Tanaka, Ryusuke Nagasawa, Takuya Nishio, Tomoyuki Shono, Junsaku Kitagawa, Ken-ichi Ogawara, Koji Shinozaki, Akiteru Seki, Mark Bruce and Tomoya Ohno
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 400-408; DOI: https://doi.org/10.1124/jpet.121.000769

P

  1. Park, Chul Min

    1. Allosteric Inhibition of the Tumor-Promoting Interaction Between Exon 2–Depleted Splice Variant of Aminoacyl–Transfer RNA Synthetase-Interacting Multifunctional Protein 2 and Heat Shock Protein 70
      Open Access
      Allosteric Inhibition of the Tumor-Promoting Interaction Between Exon 2–Depleted Splice Variant of Aminoacyl–Transfer RNA Synthetase-Interacting Multifunctional Protein 2 and Heat Shock Protein 70
      Dae Gyu Kim, Srigouri Huddar, Semi Lim, Jiwon Kong, Yuno Lee, Chul Min Park, Seungbeom Lee, Young-Ger Suh, Minkyoung Kim, Kyeong Lee, Sunkyung Lee and Sunghoon Kim
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 358-371; DOI: https://doi.org/10.1124/jpet.121.000766
  2. Parker, William B.

    1. You have access
      5-Aza-4′-thio-2′-deoxycytidine, a New Orally Bioavailable Nontoxic “Best-in-Class”: DNA Methyltransferase 1–Depleting Agent in Clinical Development
      William B. Parker and Jaideep V. Thottassery
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 211-222; DOI: https://doi.org/10.1124/jpet.121.000758
  3. Pockes, Steffen

    1. You have access
      Cardiac Effects of Novel Histamine H2 Receptor Agonists
      Ulrich Gergs, Maren L. Büxel, Merlin Bresinsky, Uwe Kirchhefer, Charlotte Fehse, Carina Höring, Britt Hofmann, Margaréta Marušáková, Aneta Čináková, Rebecca Schwarz, Steffen Pockes and Joachim Neumann
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 223-234; DOI: https://doi.org/10.1124/jpet.121.000822
  4. Pondell, Stephen M.

    1. Modulation of Oxidative Phosphorylation with IM156 Attenuates Mitochondrial Metabolic Reprogramming and Inhibits Pulmonary Fibrosis
      Open Access
      Modulation of Oxidative Phosphorylation with IM156 Attenuates Mitochondrial Metabolic Reprogramming and Inhibits Pulmonary Fibrosis
      Robert N. Willette, Parth Mangrolia, Stephen M. Pondell, Christopher Young Woo Lee, Sanghee Yoo, Marc S. Rudoltz, Benjamin R. Cowen and Dean J. Welsch
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 290-300; DOI: https://doi.org/10.1124/jpet.121.000811
  5. Pu, Zhongjian

    1. You have access
      Caspase-8 Regulates the Antimyeloma Activity of Bortezomib and Lenalidomide
      Liang Zhou, Xiangao Huang, Ruben Niesvizky, Zhongjian Pu and Guoqiang Xu
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 303-309; DOI: https://doi.org/10.1124/jpet.121.000818

Q

  1. Qiu, Yinli

    1. You have access
      A Novel Etomidate Analog EL-0052 Retains Potent Hypnotic Effect and Stable Hemodynamics without Suppressing Adrenocortical Function
      Xiangqing Xu, Yaqin Wei, Yingying Dong, Yinli Qiu, Zhanbiao Mei, Kai Wang, Jingya Xiu, Tao Wang, Lingguo Zeng, Xiaohu Dong, Yi Shen, Wengao Jiang and Qingeng Li
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 324-330; DOI: https://doi.org/10.1124/jpet.121.000691

R

  1. Rudoltz, Marc S.

    1. Modulation of Oxidative Phosphorylation with IM156 Attenuates Mitochondrial Metabolic Reprogramming and Inhibits Pulmonary Fibrosis
      Open Access
      Modulation of Oxidative Phosphorylation with IM156 Attenuates Mitochondrial Metabolic Reprogramming and Inhibits Pulmonary Fibrosis
      Robert N. Willette, Parth Mangrolia, Stephen M. Pondell, Christopher Young Woo Lee, Sanghee Yoo, Marc S. Rudoltz, Benjamin R. Cowen and Dean J. Welsch
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 290-300; DOI: https://doi.org/10.1124/jpet.121.000811
  2. Ruiz, Iliana

    1. Open Access
      Deconstructing the Pharmacological Contribution of Sphingosine-1 Phosphate Receptors to Mouse Models of Multiple Sclerosis Using the Species Selectivity of Ozanimod, a Dual Modulator of Human Sphingosine 1-Phosphate Receptor Subtypes 1 and 5
      Julie V. Selkirk, Kevin C. Dines, Yingzhuo Grace Yan, Nathan Ching, Deepak Dalvie, Shameek Biswas, Andrea Bortolato, Jeffrey M. Schkeryantz, Carlos Lopez, Iliana Ruiz and Richard Hargreaves
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 386-399; DOI: https://doi.org/10.1124/jpet.121.000741

S

  1. Sarkaria, Jann N.

    1. You have access
      Brain Distribution of Berzosertib: An Ataxia Telangiectasia and Rad3-Related Protein Inhibitor for the Treatment of Glioblastoma
      Surabhi Talele, Wenjuan Zhang, Danielle M. Burgenske, Minjee Kim, Afroz S. Mohammad, Sonja Dragojevic, Shiv K. Gupta, Ranjit S. Bindra, Jann N. Sarkaria and William F. Elmquist
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 343-357; DOI: https://doi.org/10.1124/jpet.121.000845
  2. Sasaki, Masako

    1. Open Access
      Selective Acetyl-CoA Carboxylase 1 Inhibitor Improves Hepatic Steatosis and Hepatic Fibrosis in a Preclinical Nonalcoholic Steatohepatitis Model
      Yumiko Okano Tamura, Jun Sugama, Shinji Iwasaki, Masako Sasaki, Hironobu Yasuno, Kazunobu Aoyama, Masanori Watanabe, Derek M. Erion and Hiroaki Yashiro
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 280-289; DOI: https://doi.org/10.1124/jpet.121.000786
  3. Schkeryantz, Jeffrey M.

    1. Open Access
      Deconstructing the Pharmacological Contribution of Sphingosine-1 Phosphate Receptors to Mouse Models of Multiple Sclerosis Using the Species Selectivity of Ozanimod, a Dual Modulator of Human Sphingosine 1-Phosphate Receptor Subtypes 1 and 5
      Julie V. Selkirk, Kevin C. Dines, Yingzhuo Grace Yan, Nathan Ching, Deepak Dalvie, Shameek Biswas, Andrea Bortolato, Jeffrey M. Schkeryantz, Carlos Lopez, Iliana Ruiz and Richard Hargreaves
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 386-399; DOI: https://doi.org/10.1124/jpet.121.000741
  4. Schwarz, Rebecca

    1. You have access
      Cardiac Effects of Novel Histamine H2 Receptor Agonists
      Ulrich Gergs, Maren L. Büxel, Merlin Bresinsky, Uwe Kirchhefer, Charlotte Fehse, Carina Höring, Britt Hofmann, Margaréta Marušáková, Aneta Čináková, Rebecca Schwarz, Steffen Pockes and Joachim Neumann
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 223-234; DOI: https://doi.org/10.1124/jpet.121.000822
  5. Seebohm, Guiscard

    1. You have access
      Selective Inhibition of N-Methyl-d-aspartate Receptors with GluN2B Subunit Protects β Cells against Stress-Induced Apoptotic Cell Death
      Anne Gresch, Héctor Noguera Hurtado, Laura Wörmeyer, Vivien De Luca, Rebekka Wiggers, Guiscard Seebohm, Bernhard Wünsch and Martina Düfer
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 235-244; DOI: https://doi.org/10.1124/jpet.121.000807
  6. Seki, Akiteru

    1. You have access
      Novel Platform for Predicting Drug Effects in Patients with Acromegaly: Translational Exposure-Response Evaluation of Growth Hormone–Inhibitory Effect of Octreotide after Growth Hormone–Releasing Hormone Stimulation
      Hiroyuki Iida, Tatsuya Komagata, Hirotaka Tanaka, Ryusuke Nagasawa, Takuya Nishio, Tomoyuki Shono, Junsaku Kitagawa, Ken-ichi Ogawara, Koji Shinozaki, Akiteru Seki, Mark Bruce and Tomoya Ohno
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 400-408; DOI: https://doi.org/10.1124/jpet.121.000769
  7. Selkirk, Julie V.

    1. Open Access
      Deconstructing the Pharmacological Contribution of Sphingosine-1 Phosphate Receptors to Mouse Models of Multiple Sclerosis Using the Species Selectivity of Ozanimod, a Dual Modulator of Human Sphingosine 1-Phosphate Receptor Subtypes 1 and 5
      Julie V. Selkirk, Kevin C. Dines, Yingzhuo Grace Yan, Nathan Ching, Deepak Dalvie, Shameek Biswas, Andrea Bortolato, Jeffrey M. Schkeryantz, Carlos Lopez, Iliana Ruiz and Richard Hargreaves
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 386-399; DOI: https://doi.org/10.1124/jpet.121.000741
  8. Sharabi, Yehonatan

    1. Differential Susceptibilities of Catecholamines to Metabolism by Monoamine Oxidases
      You have access
      Differential Susceptibilities of Catecholamines to Metabolism by Monoamine Oxidases
      David S. Goldstein, Genessis Castillo, Patti Sullivan and Yehonatan Sharabi
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 253-259; DOI: https://doi.org/10.1124/jpet.121.000826
  9. Shen, Yi

    1. You have access
      A Novel Etomidate Analog EL-0052 Retains Potent Hypnotic Effect and Stable Hemodynamics without Suppressing Adrenocortical Function
      Xiangqing Xu, Yaqin Wei, Yingying Dong, Yinli Qiu, Zhanbiao Mei, Kai Wang, Jingya Xiu, Tao Wang, Lingguo Zeng, Xiaohu Dong, Yi Shen, Wengao Jiang and Qingeng Li
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 324-330; DOI: https://doi.org/10.1124/jpet.121.000691
  10. Shinozaki, Koji

    1. You have access
      Novel Platform for Predicting Drug Effects in Patients with Acromegaly: Translational Exposure-Response Evaluation of Growth Hormone–Inhibitory Effect of Octreotide after Growth Hormone–Releasing Hormone Stimulation
      Hiroyuki Iida, Tatsuya Komagata, Hirotaka Tanaka, Ryusuke Nagasawa, Takuya Nishio, Tomoyuki Shono, Junsaku Kitagawa, Ken-ichi Ogawara, Koji Shinozaki, Akiteru Seki, Mark Bruce and Tomoya Ohno
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 400-408; DOI: https://doi.org/10.1124/jpet.121.000769
  11. Shnider, Sara

    1. Open Access
      A Monoclonal Anti–Calcitonin Gene-Related Peptide Antibody Decreases Stress-Induced Colonic Hypersensitivity
      Ehsan Noor-Mohammadi, Casey Owen Ligon, Kimberly Mackenzie, Jennifer Stratton, Sara Shnider and Beverley Greenwood-Van Meerveld
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 270-279; DOI: https://doi.org/10.1124/jpet.121.000731
  12. Shono, Tomoyuki

    1. You have access
      Novel Platform for Predicting Drug Effects in Patients with Acromegaly: Translational Exposure-Response Evaluation of Growth Hormone–Inhibitory Effect of Octreotide after Growth Hormone–Releasing Hormone Stimulation
      Hiroyuki Iida, Tatsuya Komagata, Hirotaka Tanaka, Ryusuke Nagasawa, Takuya Nishio, Tomoyuki Shono, Junsaku Kitagawa, Ken-ichi Ogawara, Koji Shinozaki, Akiteru Seki, Mark Bruce and Tomoya Ohno
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 400-408; DOI: https://doi.org/10.1124/jpet.121.000769
  13. Singh, Gagandeep

    1. Physiologic, Metabolic, and Toxicologic Profile of 1,3-Butanediol
      You have access
      Physiologic, Metabolic, and Toxicologic Profile of 1,3-Butanediol
      Cameron G. McCarthy, Emily W. Waigi, Gagandeep Singh, Thaddaeus R. Castaneda, Blair Mell, Saroj Chakraborty, Camilla F. Wenceslau and Bina Joe
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 245-252; DOI: https://doi.org/10.1124/jpet.121.000796
  14. Stratton, Jennifer

    1. Open Access
      A Monoclonal Anti–Calcitonin Gene-Related Peptide Antibody Decreases Stress-Induced Colonic Hypersensitivity
      Ehsan Noor-Mohammadi, Casey Owen Ligon, Kimberly Mackenzie, Jennifer Stratton, Sara Shnider and Beverley Greenwood-Van Meerveld
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 270-279; DOI: https://doi.org/10.1124/jpet.121.000731
  15. Sugama, Jun

    1. Open Access
      Selective Acetyl-CoA Carboxylase 1 Inhibitor Improves Hepatic Steatosis and Hepatic Fibrosis in a Preclinical Nonalcoholic Steatohepatitis Model
      Yumiko Okano Tamura, Jun Sugama, Shinji Iwasaki, Masako Sasaki, Hironobu Yasuno, Kazunobu Aoyama, Masanori Watanabe, Derek M. Erion and Hiroaki Yashiro
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 280-289; DOI: https://doi.org/10.1124/jpet.121.000786
  16. Suh, Young-Ger

    1. Allosteric Inhibition of the Tumor-Promoting Interaction Between Exon 2–Depleted Splice Variant of Aminoacyl–Transfer RNA Synthetase-Interacting Multifunctional Protein 2 and Heat Shock Protein 70
      Open Access
      Allosteric Inhibition of the Tumor-Promoting Interaction Between Exon 2–Depleted Splice Variant of Aminoacyl–Transfer RNA Synthetase-Interacting Multifunctional Protein 2 and Heat Shock Protein 70
      Dae Gyu Kim, Srigouri Huddar, Semi Lim, Jiwon Kong, Yuno Lee, Chul Min Park, Seungbeom Lee, Young-Ger Suh, Minkyoung Kim, Kyeong Lee, Sunkyung Lee and Sunghoon Kim
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 358-371; DOI: https://doi.org/10.1124/jpet.121.000766
  17. Sullivan, Patti

    1. Differential Susceptibilities of Catecholamines to Metabolism by Monoamine Oxidases
      You have access
      Differential Susceptibilities of Catecholamines to Metabolism by Monoamine Oxidases
      David S. Goldstein, Genessis Castillo, Patti Sullivan and Yehonatan Sharabi
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 253-259; DOI: https://doi.org/10.1124/jpet.121.000826

T

  1. Talele, Surabhi

    1. You have access
      Brain Distribution of Berzosertib: An Ataxia Telangiectasia and Rad3-Related Protein Inhibitor for the Treatment of Glioblastoma
      Surabhi Talele, Wenjuan Zhang, Danielle M. Burgenske, Minjee Kim, Afroz S. Mohammad, Sonja Dragojevic, Shiv K. Gupta, Ranjit S. Bindra, Jann N. Sarkaria and William F. Elmquist
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 343-357; DOI: https://doi.org/10.1124/jpet.121.000845
  2. Tamura, Yumiko Okano

    1. Open Access
      Selective Acetyl-CoA Carboxylase 1 Inhibitor Improves Hepatic Steatosis and Hepatic Fibrosis in a Preclinical Nonalcoholic Steatohepatitis Model
      Yumiko Okano Tamura, Jun Sugama, Shinji Iwasaki, Masako Sasaki, Hironobu Yasuno, Kazunobu Aoyama, Masanori Watanabe, Derek M. Erion and Hiroaki Yashiro
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 280-289; DOI: https://doi.org/10.1124/jpet.121.000786
  3. Tanaka, Hirotaka

    1. You have access
      Novel Platform for Predicting Drug Effects in Patients with Acromegaly: Translational Exposure-Response Evaluation of Growth Hormone–Inhibitory Effect of Octreotide after Growth Hormone–Releasing Hormone Stimulation
      Hiroyuki Iida, Tatsuya Komagata, Hirotaka Tanaka, Ryusuke Nagasawa, Takuya Nishio, Tomoyuki Shono, Junsaku Kitagawa, Ken-ichi Ogawara, Koji Shinozaki, Akiteru Seki, Mark Bruce and Tomoya Ohno
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 400-408; DOI: https://doi.org/10.1124/jpet.121.000769
  4. Thottassery, Jaideep V.

    1. You have access
      5-Aza-4′-thio-2′-deoxycytidine, a New Orally Bioavailable Nontoxic “Best-in-Class”: DNA Methyltransferase 1–Depleting Agent in Clinical Development
      William B. Parker and Jaideep V. Thottassery
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 211-222; DOI: https://doi.org/10.1124/jpet.121.000758

V

  1. Vaidya, Bhuvaneshwar

    1. You have access
      Glutamate Buffering Capacity and Blood-Brain Barrier Protection of Opioid Receptor Agonists Biphalin and Nociceptin
      Saeideh Nozohouri, Yong Zhang, Thamer H. Albekairi, Bhuvaneshwar Vaidya and Thomas J. Abbruscato
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 260-269; DOI: https://doi.org/10.1124/jpet.121.000831
  2. Van Eaton, Kristen M.

    1. You have access
      Pharmacokinetic and Pharmacodynamic Assessment of Hydroxychloroquine in Breast Cancer
      Kristen M. Van Eaton and Daniel L. Gustafson
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 331-342; DOI: https://doi.org/10.1124/jpet.121.000730

W

  1. Waigi, Emily W.

    1. Physiologic, Metabolic, and Toxicologic Profile of 1,3-Butanediol
      You have access
      Physiologic, Metabolic, and Toxicologic Profile of 1,3-Butanediol
      Cameron G. McCarthy, Emily W. Waigi, Gagandeep Singh, Thaddaeus R. Castaneda, Blair Mell, Saroj Chakraborty, Camilla F. Wenceslau and Bina Joe
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 245-252; DOI: https://doi.org/10.1124/jpet.121.000796
  2. Wang, Kai

    1. You have access
      A Novel Etomidate Analog EL-0052 Retains Potent Hypnotic Effect and Stable Hemodynamics without Suppressing Adrenocortical Function
      Xiangqing Xu, Yaqin Wei, Yingying Dong, Yinli Qiu, Zhanbiao Mei, Kai Wang, Jingya Xiu, Tao Wang, Lingguo Zeng, Xiaohu Dong, Yi Shen, Wengao Jiang and Qingeng Li
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 324-330; DOI: https://doi.org/10.1124/jpet.121.000691
  3. Wang, Tao

    1. You have access
      A Novel Etomidate Analog EL-0052 Retains Potent Hypnotic Effect and Stable Hemodynamics without Suppressing Adrenocortical Function
      Xiangqing Xu, Yaqin Wei, Yingying Dong, Yinli Qiu, Zhanbiao Mei, Kai Wang, Jingya Xiu, Tao Wang, Lingguo Zeng, Xiaohu Dong, Yi Shen, Wengao Jiang and Qingeng Li
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 324-330; DOI: https://doi.org/10.1124/jpet.121.000691
  4. Watanabe, Masanori

    1. Open Access
      Selective Acetyl-CoA Carboxylase 1 Inhibitor Improves Hepatic Steatosis and Hepatic Fibrosis in a Preclinical Nonalcoholic Steatohepatitis Model
      Yumiko Okano Tamura, Jun Sugama, Shinji Iwasaki, Masako Sasaki, Hironobu Yasuno, Kazunobu Aoyama, Masanori Watanabe, Derek M. Erion and Hiroaki Yashiro
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 280-289; DOI: https://doi.org/10.1124/jpet.121.000786
  5. Wei, Yaqin

    1. You have access
      A Novel Etomidate Analog EL-0052 Retains Potent Hypnotic Effect and Stable Hemodynamics without Suppressing Adrenocortical Function
      Xiangqing Xu, Yaqin Wei, Yingying Dong, Yinli Qiu, Zhanbiao Mei, Kai Wang, Jingya Xiu, Tao Wang, Lingguo Zeng, Xiaohu Dong, Yi Shen, Wengao Jiang and Qingeng Li
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 324-330; DOI: https://doi.org/10.1124/jpet.121.000691
  6. Welsch, Dean J.

    1. Modulation of Oxidative Phosphorylation with IM156 Attenuates Mitochondrial Metabolic Reprogramming and Inhibits Pulmonary Fibrosis
      Open Access
      Modulation of Oxidative Phosphorylation with IM156 Attenuates Mitochondrial Metabolic Reprogramming and Inhibits Pulmonary Fibrosis
      Robert N. Willette, Parth Mangrolia, Stephen M. Pondell, Christopher Young Woo Lee, Sanghee Yoo, Marc S. Rudoltz, Benjamin R. Cowen and Dean J. Welsch
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 290-300; DOI: https://doi.org/10.1124/jpet.121.000811
  7. Wenceslau, Camilla F.

    1. Physiologic, Metabolic, and Toxicologic Profile of 1,3-Butanediol
      You have access
      Physiologic, Metabolic, and Toxicologic Profile of 1,3-Butanediol
      Cameron G. McCarthy, Emily W. Waigi, Gagandeep Singh, Thaddaeus R. Castaneda, Blair Mell, Saroj Chakraborty, Camilla F. Wenceslau and Bina Joe
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 245-252; DOI: https://doi.org/10.1124/jpet.121.000796
  8. Wiggers, Rebekka

    1. You have access
      Selective Inhibition of N-Methyl-d-aspartate Receptors with GluN2B Subunit Protects β Cells against Stress-Induced Apoptotic Cell Death
      Anne Gresch, Héctor Noguera Hurtado, Laura Wörmeyer, Vivien De Luca, Rebekka Wiggers, Guiscard Seebohm, Bernhard Wünsch and Martina Düfer
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 235-244; DOI: https://doi.org/10.1124/jpet.121.000807
  9. Willette, Robert N.

    1. Modulation of Oxidative Phosphorylation with IM156 Attenuates Mitochondrial Metabolic Reprogramming and Inhibits Pulmonary Fibrosis
      Open Access
      Modulation of Oxidative Phosphorylation with IM156 Attenuates Mitochondrial Metabolic Reprogramming and Inhibits Pulmonary Fibrosis
      Robert N. Willette, Parth Mangrolia, Stephen M. Pondell, Christopher Young Woo Lee, Sanghee Yoo, Marc S. Rudoltz, Benjamin R. Cowen and Dean J. Welsch
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 290-300; DOI: https://doi.org/10.1124/jpet.121.000811
  10. Wörmeyer, Laura

    1. You have access
      Selective Inhibition of N-Methyl-d-aspartate Receptors with GluN2B Subunit Protects β Cells against Stress-Induced Apoptotic Cell Death
      Anne Gresch, Héctor Noguera Hurtado, Laura Wörmeyer, Vivien De Luca, Rebekka Wiggers, Guiscard Seebohm, Bernhard Wünsch and Martina Düfer
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 235-244; DOI: https://doi.org/10.1124/jpet.121.000807
  11. Wünsch, Bernhard

    1. You have access
      Selective Inhibition of N-Methyl-d-aspartate Receptors with GluN2B Subunit Protects β Cells against Stress-Induced Apoptotic Cell Death
      Anne Gresch, Héctor Noguera Hurtado, Laura Wörmeyer, Vivien De Luca, Rebekka Wiggers, Guiscard Seebohm, Bernhard Wünsch and Martina Düfer
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 235-244; DOI: https://doi.org/10.1124/jpet.121.000807

X

  1. Xiu, Jingya

    1. You have access
      A Novel Etomidate Analog EL-0052 Retains Potent Hypnotic Effect and Stable Hemodynamics without Suppressing Adrenocortical Function
      Xiangqing Xu, Yaqin Wei, Yingying Dong, Yinli Qiu, Zhanbiao Mei, Kai Wang, Jingya Xiu, Tao Wang, Lingguo Zeng, Xiaohu Dong, Yi Shen, Wengao Jiang and Qingeng Li
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 324-330; DOI: https://doi.org/10.1124/jpet.121.000691
  2. Xu, Guoqiang

    1. You have access
      Caspase-8 Regulates the Antimyeloma Activity of Bortezomib and Lenalidomide
      Liang Zhou, Xiangao Huang, Ruben Niesvizky, Zhongjian Pu and Guoqiang Xu
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 303-309; DOI: https://doi.org/10.1124/jpet.121.000818
  3. Xu, Xiangqing

    1. You have access
      A Novel Etomidate Analog EL-0052 Retains Potent Hypnotic Effect and Stable Hemodynamics without Suppressing Adrenocortical Function
      Xiangqing Xu, Yaqin Wei, Yingying Dong, Yinli Qiu, Zhanbiao Mei, Kai Wang, Jingya Xiu, Tao Wang, Lingguo Zeng, Xiaohu Dong, Yi Shen, Wengao Jiang and Qingeng Li
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 324-330; DOI: https://doi.org/10.1124/jpet.121.000691

Y

  1. Yan, Yingzhuo Grace

    1. Open Access
      Deconstructing the Pharmacological Contribution of Sphingosine-1 Phosphate Receptors to Mouse Models of Multiple Sclerosis Using the Species Selectivity of Ozanimod, a Dual Modulator of Human Sphingosine 1-Phosphate Receptor Subtypes 1 and 5
      Julie V. Selkirk, Kevin C. Dines, Yingzhuo Grace Yan, Nathan Ching, Deepak Dalvie, Shameek Biswas, Andrea Bortolato, Jeffrey M. Schkeryantz, Carlos Lopez, Iliana Ruiz and Richard Hargreaves
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 386-399; DOI: https://doi.org/10.1124/jpet.121.000741
  2. Yashiro, Hiroaki

    1. Open Access
      Selective Acetyl-CoA Carboxylase 1 Inhibitor Improves Hepatic Steatosis and Hepatic Fibrosis in a Preclinical Nonalcoholic Steatohepatitis Model
      Yumiko Okano Tamura, Jun Sugama, Shinji Iwasaki, Masako Sasaki, Hironobu Yasuno, Kazunobu Aoyama, Masanori Watanabe, Derek M. Erion and Hiroaki Yashiro
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 280-289; DOI: https://doi.org/10.1124/jpet.121.000786
  3. Yasuno, Hironobu

    1. Open Access
      Selective Acetyl-CoA Carboxylase 1 Inhibitor Improves Hepatic Steatosis and Hepatic Fibrosis in a Preclinical Nonalcoholic Steatohepatitis Model
      Yumiko Okano Tamura, Jun Sugama, Shinji Iwasaki, Masako Sasaki, Hironobu Yasuno, Kazunobu Aoyama, Masanori Watanabe, Derek M. Erion and Hiroaki Yashiro
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 280-289; DOI: https://doi.org/10.1124/jpet.121.000786
  4. Yoo, Sanghee

    1. Modulation of Oxidative Phosphorylation with IM156 Attenuates Mitochondrial Metabolic Reprogramming and Inhibits Pulmonary Fibrosis
      Open Access
      Modulation of Oxidative Phosphorylation with IM156 Attenuates Mitochondrial Metabolic Reprogramming and Inhibits Pulmonary Fibrosis
      Robert N. Willette, Parth Mangrolia, Stephen M. Pondell, Christopher Young Woo Lee, Sanghee Yoo, Marc S. Rudoltz, Benjamin R. Cowen and Dean J. Welsch
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 290-300; DOI: https://doi.org/10.1124/jpet.121.000811

Z

  1. Zeng, Lingguo

    1. You have access
      A Novel Etomidate Analog EL-0052 Retains Potent Hypnotic Effect and Stable Hemodynamics without Suppressing Adrenocortical Function
      Xiangqing Xu, Yaqin Wei, Yingying Dong, Yinli Qiu, Zhanbiao Mei, Kai Wang, Jingya Xiu, Tao Wang, Lingguo Zeng, Xiaohu Dong, Yi Shen, Wengao Jiang and Qingeng Li
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 324-330; DOI: https://doi.org/10.1124/jpet.121.000691
  2. Zhang, Wenjuan

    1. You have access
      Brain Distribution of Berzosertib: An Ataxia Telangiectasia and Rad3-Related Protein Inhibitor for the Treatment of Glioblastoma
      Surabhi Talele, Wenjuan Zhang, Danielle M. Burgenske, Minjee Kim, Afroz S. Mohammad, Sonja Dragojevic, Shiv K. Gupta, Ranjit S. Bindra, Jann N. Sarkaria and William F. Elmquist
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 343-357; DOI: https://doi.org/10.1124/jpet.121.000845
  3. Zhang, Yong

    1. You have access
      Glutamate Buffering Capacity and Blood-Brain Barrier Protection of Opioid Receptor Agonists Biphalin and Nociceptin
      Saeideh Nozohouri, Yong Zhang, Thamer H. Albekairi, Bhuvaneshwar Vaidya and Thomas J. Abbruscato
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 260-269; DOI: https://doi.org/10.1124/jpet.121.000831
  4. Zhou, Liang

    1. You have access
      Caspase-8 Regulates the Antimyeloma Activity of Bortezomib and Lenalidomide
      Liang Zhou, Xiangao Huang, Ruben Niesvizky, Zhongjian Pu and Guoqiang Xu
      Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 303-309; DOI: https://doi.org/10.1124/jpet.121.000818
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics: 379 (3)
Journal of Pharmacology and Experimental Therapeutics
Vol. 379, Issue 3
1 Dec 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics